MedTrace Logo

Improved Selection of Elderly (> 65 Years) for Kidney Transplantation

NCT01760733 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 289

Last updated 2020-04-24

Study results available
· View outcomes & findings →

Summary

Kidney transplantation has been shown to provide improved survival even in patients older than 70 years of age. The purpose of the study is to determine whether kidney transplantation provides any improvement of health related quality of life (HRQOL) in patients over the age of 65 years. HRQOL wil be monitored using the Kidney Disease and Quality of Life (KDQOL-SF)form. Patients will be recruited at the time of acceptance to the Norwegian transplant wait list and followed every 6 months until transplantation. Thereafter a new form will be completed after 10 weeks post transplant, 6 months, 1 year, 3 years and 5 years. In addition the study will explore the transplant candidates expectations in a qualitative study design and explore the relationship between pre-transplant comorbidity, HRQOL and survival.

Conditions

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • Sykehuset Telemark

    lead OTHER_GOV

Principal Investigators

  • Kristian Heldal, MD, PhD · Sykehuset Telemark

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01760733 on ClinicalTrials.gov